Verogen Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Verogen's estimated annual revenue is currently $11.5M per year.(i)
  • Verogen's estimated revenue per employee is $155,000

Employee Data

  • Verogen has 74 Employees.(i)
  • Verogen grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.3M7122%N/AN/A

Introducing the world's first sequencing company solely dedicated to forensic science. Verogen serves those who pursue the truth. It's about advancing next-generation sequencing to help unlock the true potential of forensic genomics. Supporting labs with solutions and expert service purpose-built for the challenges of human identification. And, ultimately, committing to effectively and efficiently ensuring justice, security, and public wellness - for all.

keywords:N/A

N/A

Total Funding

74

Number of Employees

$11.5M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Verogen News

2022-04-13 - Molecular Forensics Market Size, Share, Growth, Trends and ...

Verogen, Inc. Thermo Fisher Scientific Inc. QIAGEN N.V.; Promega Corporation; Merck KGaA; MACHEREY-NAGEL GmbH & Co KG; LGC Limited; Illumina,...

2019-09-12 - CFSRE and Verogen Team Up to Accelerate the ...

WILLOW GROVE, Pa. & SAN DIEGO--(BUSINESS WIRE)--The Center for Forensic Science Research & Education (CFSRE) and Verogen have ...

2019-09-12 - Verogen Inks Collaboration Agreement With Center for ...

NEW YORK – Verogen and the Center for Forensic Science Research & Education (CFSRE) said today that they are collaborating on the ...

2019-09-12 - CFSRE and Verogen join forces to accelerate implementation of new forensic NGS technology

The Center for Forensic Science Research & Education (CFSRE) and Verogen have entered into a collaborative agreement to establish ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.3M7428%$20M
#2
$18M74-3%N/A
#3
$14M74-4%N/A
#4
$10.2M7430%$261.5M
#5
$13.7M740%N/A